J. Haduong, A. Martin, S. Skapek, and M. L. Sarcomas, Sarcomas, Pediatric Clinics of North America, vol.62, issue.1, pp.179-200, 2015.
DOI : 10.1016/j.pcl.2014.09.012

R. Williams, I. Fernandez-pineda, and A. Gosain, Pediatric Sarcomas. Surgical Clinics of North America, pp.1107-1125, 2016.

P. Leavey, Important principles in Ewing sarcoma treatment, Pediatric Blood & Cancer, vol.52, issue.12, pp.2149-2150, 2014.
DOI : 10.1002/pbc.21889

A. Luetke, P. Meyers, I. Lewis, and H. Juergens, Osteosarcoma treatment ??? Where do we stand? A state of the art review, Cancer Treatment Reviews, vol.40, issue.4, pp.523-532, 2014.
DOI : 10.1016/j.ctrv.2013.11.006

T. Ozaki, Diagnosis and treatment of Ewing sarcoma of the bone: a review article, Journal of Orthopaedic Science, vol.20, issue.2, pp.250-263, 2015.
DOI : 10.1007/s00776-014-0687-z

L. Guerra, J. Márquez-vega, C. Ramírez-villar, G. Cabrera, P. Ordóñez et al., Prognostic factors for overall survival in paediatric patients with Ewing sarcoma of bone treated according to multidisciplinary protocol, Clinical and Translational Oncology, vol.15, issue.[Suppl1], pp.294-301, 2012.
DOI : 10.1007/BF00263897

K. Duchman, Y. Gao, and B. Miller, Prognostic factors for survival in patients with Ewing's sarcoma using the surveillance, epidemiology, and end results (SEER) program database, Cancer Epidemiology, vol.39, issue.2, pp.189-195, 2015.
DOI : 10.1016/j.canep.2014.12.012

D. Hawkins, J. Rajendran, E. Conrad, J. Bruckner, and J. Eary, Evaluation of chemotherapy response in pediatric bone sarcomas by [F-18]-fluorodeoxy-D-glucose positron emission tomography, Cancer, vol.72, issue.12, pp.3277-3284, 2002.
DOI : 10.1002/1097-0142(19931201)72:11<3227::AID-CNCR2820721116>3.0.CO;2-C

T. Denecke, P. Hundsdörfer, D. Misch, I. Steffen, S. Schönberger et al., Assessment of histological response of paediatric bone sarcomas using FDG PET in comparison to morphological volume measurement and standardized MRI parameters, European Journal of Nuclear Medicine and Molecular Imaging, vol.50, issue.9, pp.1842-1853, 2010.
DOI : 10.1002/1097-0142(19910215)67:4+<1169::AID-CNCR2820671511>3.0.CO;2-A

J. Guimarães, L. Rigo, F. Lewin, and A. Emerick, The importance of PET/CT in the evaluation of patients with Ewing tumors, Radiologia Brasileira, vol.187, issue.15S, pp.175-180, 2015.
DOI : 10.2214/AJR.06.0171

N. Quartuccio, J. Fox, D. Kuk, L. Wexler, S. Baldari et al., F-FDG PET/CT Versus Conventional Imaging for Initial Staging and Follow-Up, American Journal of Roentgenology, vol.204, issue.1
DOI : 10.2214/AJR.14.12932

C. Costelloe, H. Macapinlac, J. Madewell, N. Fitzgerald, O. Mawlawi et al., 18F-FDG PET/CT as an Indicator of Progression-Free and Overall Survival in Osteosarcoma, Journal of Nuclear Medicine, vol.50, issue.3, pp.340-347, 2009.
DOI : 10.2967/jnumed.108.058461

B. Byun, C. Kong, J. Park, Y. Seo, I. Lim et al., Initial Metabolic Tumor Volume Measured by 18F-FDG PET/CT Can Predict the Outcome of Osteosarcoma of the Extremities, Journal of Nuclear Medicine, vol.54, issue.10, pp.1725-1732, 2013.
DOI : 10.2967/jnumed.112.117697

B. Byun, C. Kong, I. Lim, B. Kim, C. Choi et al., Early response monitoring to neoadjuvant chemotherapy in osteosarcoma using sequential 18???F-FDG PET/CT and MRI, European Journal of Nuclear Medicine and Molecular Imaging, vol.50, issue.Suppl, pp.1553-1562, 2014.
DOI : 10.2967/jnumed.108.057455

E. Palmerini, M. Colangeli, C. Nanni, S. Fanti, E. Marchesi et al., The role of FDG PET/CT in patients treated with neoadjuvant chemotherapy for localized bone sarcomas, European Journal of Nuclear Medicine and Molecular Imaging, vol.26, issue.2, p.27645694, 2016.
DOI : 10.1093/annonc/mdu526

A. Raciborska, K. Bilska, K. Drabko, E. Michalak, R. Chaber et al., Response to chemotherapy estimates by FDG PET is an important prognostic factor in patients with Ewing sarcoma, Clinical and Translational Oncology, vol.27, issue.8, pp.189-195, 2016.
DOI : 10.1097/01.mnm.0000237986.31597.86

E. Eisenhauer, P. Therasse, J. Bogaerts, L. Schwartz, D. Sargent et al., New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1), European Journal of Cancer, vol.45, issue.2, pp.228-247, 2009.
DOI : 10.1016/j.ejca.2008.10.026

C. Bailly, C. Bodet-milin, S. Couespel, H. Necib, F. Kraeber-bodéré et al., Revisiting the Robustness of PET-Based Textural Features in the Context of Multi-Centric Trials, PLOS ONE, vol.195, issue.7, p.27467882, 2016.
DOI : 10.1371/journal.pone.0159984.s004

URL : https://hal.archives-ouvertes.fr/inserm-01414301

M. Hatt, M. Majdoub, M. Vallières, F. Tixier, C. Rest et al., 18F-FDG PET Uptake Characterization Through Texture Analysis: Investigating the Complementary Nature of Heterogeneity and Functional Tumor Volume in a Multi-Cancer Site Patient Cohort, Journal of Nuclear Medicine, vol.56, issue.1, pp.38-44, 2015.
DOI : 10.2967/jnumed.114.144055

O. Sullivan, F. Wolsztynski, E. , O. Sullivan, J. Richards et al., A Statistical Modeling Approach to the Analysis of Spatial Patterns of FDG-PET Uptake in Human Sarcoma, IEEE Transactions on Medical Imaging, vol.30, issue.12, pp.2059-2071, 2011.
DOI : 10.1109/TMI.2011.2160984

S. Vauclin, K. Doyeux, S. Hapdey, A. Edet-sanson, P. Vera et al., Development of a generic thresholding algorithm for the delineation of 18FDG-PET-positive tissue: application to the comparison of three thresholding models, Phys Med Biol, vol.545422, pp.6901-69160031, 2009.
URL : https://hal.archives-ouvertes.fr/inserm-00467195

R. Wahl, H. Jacene, Y. Kasamon, and M. Lodge, From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors, Journal of Nuclear Medicine, vol.50, issue.Suppl_1, pp.122-150, 2009.
DOI : 10.2967/jnumed.108.057307

URL : http://jnm.snmjournals.org/content/50/Suppl_1/122S.full.pdf

M. Salzer-kuntschik, G. Delling, G. Beron, and S. R. , Morphological grades of regression in osteosarcoma after polychemotherapy ? Study COSS 80, Journal of Cancer Research and Clinical Oncology, vol.106, issue.S1, pp.21-24, 1983.
DOI : 10.1007/BF00625047

L. Hongtao, Z. Hui, W. Bingshun, W. Xiaojin, W. Zhiyu et al., 18F-FDG positron emission tomography for the assessment of histological response to neoadjuvant chemotherapy in osteosarcomas: A meta-analysis, Surgical Oncology, vol.21, issue.4, pp.165-170, 2012.
DOI : 10.1016/j.suronc.2012.07.002

J. Meyer, H. Nadel, N. Marina, R. Womer, K. Brown et al., Imaging guidelines for children with Ewing sarcoma and osteosarcoma: A report from the Children's Oncology Group Bone Tumor Committee, Pediatric Blood & Cancer, vol.23, issue.2, pp.163-170, 2008.
DOI : 10.2214/ajr.176.2.1760289

C. Franzius, S. Bielack, S. Flege, J. Sciuk, H. Jürgens et al., Prognostic significance of 18F-FDG and 99mTc-methylene diphosphonate uptake in primary osteosarcoma, Journal of Nuclear Medicine, vol.43, pp.1012-1017, 2002.

S. Bielack, B. Kempf-bielack, V. Kalle, T. Schwarz, R. Wirth et al., Controversies in childhood osteosarcoma, Minerva Pediatr, vol.65, pp.125-148, 2013.

K. Janeway, D. Barkauskas, M. Krailo, P. Meyers, C. Schwartz et al., Outcome for adolescent and young adult patients with osteosarcoma, Cancer, vol.27, issue.18, pp.4597-4605, 2012.
DOI : 10.1200/JCO.2007.15.4542

URL : http://onlinelibrary.wiley.com/doi/10.1002/cncr.27414/pdf

G. Bacci, A. Longhi, M. Versari, M. Mercuri, A. Briccoli et al., Prognostic factors for osteosarcoma of the extremity treated with neoadjuvant chemotherapy, Cancer, vol.10, issue.5, pp.1154-1161, 2006.
DOI : 10.1007/978-1-4615-3518-8_42

S. Cotterill, S. Ahrens, M. Paulussen, H. Jürgens, P. Voûte et al., Prognostic Factors in Ewing???s Tumor of Bone: Analysis of 975 Patients From the European Intergroup Cooperative Ewing???s Sarcoma Study Group, Journal of Clinical Oncology, vol.18, issue.17, pp.3108-3114, 2000.
DOI : 10.1200/JCO.2000.18.17.3108

E. Kolb, B. Kushner, R. Gorlick, C. Laverdiere, J. Healey et al., Long-Term Event-Free Survival After Intensive Chemotherapy for Ewing???s Family of Tumors in Children and Young Adults, Journal of Clinical Oncology, vol.21, issue.18, pp.3423-3430, 2003.
DOI : 10.1200/JCO.2003.10.033

T. Carlier and C. Bailly, State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET, Frontiers in Medicine, vol.14, issue.Suppl 1, pp.18-26090365, 2015.
DOI : 10.3348/kjr.2013.14.1.1

L. Gaston, D. Bella, C. Slavin, J. Hicks, R. Choong et al., 18F-FDG PET response to neoadjuvant chemotherapy for Ewing sarcoma and osteosarcoma are different, Skeletal Radiology, vol.59, issue.2, pp.1007-1015, 2011.
DOI : 10.1002/1097-0142(19870115)59:2<252::AID-CNCR2820590213>3.0.CO;2-P

N. Nair, A. A. Green, A. Lamonica, G. Alibazoglu, H. Alibazoglu et al., Response of Osteosarcoma to Chemotherapy Evaluation with F-18 FDG-PET Scans, Clinical Positron Imaging, vol.3, issue.2, pp.79-83, 2000.
DOI : 10.1016/S1095-0397(00)00037-6